Dr. Scott Dudak, MD

Dr. Dudak practices at Los Alamos Medical Center in Los Alamos, New Mexico, part of Lifepoint Health.

Dr. Dudak's NPI, 1831139351, was assigned on June 7, 2006. Dr. Dudak graduated from Boston University School Of Medicine in 1991. Dr. Dudak holds Florida license 64623.

Dr. Dudak's primary practice is Los Alamos Medical Center, at 3917 West Road, Los Alamos, NM 87544 in Los Alamos County. The practice phone is (505) 662-4201.

Dr. Dudak's primary practice is Los Alamos Medical Center in Los Alamos, New Mexico, part of Lifepoint Health. Dr. Dudak is also affiliated with Salem Hospital. The medical group on file is Los Alamos Physician Practices. Dmand AI also links Dr. Dudak to 2 more hospitals, 3 medical groups, 2 group practices and clinics and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dudak practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Dudak's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Dudak is board certified in urology by the American Board of Urology. Dmand AI has Dr. Dudak's licenses on file in 5 states: Florida, Montana, Utah, Ohio and Oregon.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and testicular dysfunction among the conditions Dr. Dudak treats.

CMS data shows 359 Medicare services from Dr. Dudak across 7 procedure codes in 2024, for 202 Medicare patients. Medicare paid $18,089 for them. Every service was in an office.

CMS counts 202 Medicare patients who saw Dr. Dudak in 2026. The largest group is 65 to 74, with 96 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dudak's median patient age at 72, with 26% women.

In 2026, Dr. Dudak wrote 395 Medicare Part D claims for 156 patients. 90% of them were for generic drugs. CMS names the drug for 316 of them, across 6 drugs with 11 or more claims each, at $24,290 in total drug cost. In 2023, CMS named 771 claims across 16 drugs.

Dr. Dudak accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Dudak. Dr. Dudak's most frequent co-authors are Rafael A. Antun, MD, Rafael Gosalbez, MD and Carmen A. Puliafito, MD.

CMS Open Payments shows 90 general payments to Dr. Dudak from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 47% of the total. Dendreon Pharmaceuticals LLC paid the most, $2,130.

Dmand AI lists 2 awards for Dr. Dudak, most recently Regional Top Doctor in 2014.

Dr. Dudak graduated from Boston University School Of Medicine in 1991. Dr. Dudak is a member of ACS.

Dr. Dudak is in network with 14 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.